KURA FY 2020 Earnings — Kura Oncology, Inc. Revenue & Financial Results | Market Cap Arena

KURAKura Oncology, Inc.

$774M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$194,000

Operating Income

-$92M

Net Income

-$90M

EPS (Diluted)

$-1.69

Cash Flow

Operating Cash Flow

-$70M

Free Cash Flow

-$72M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$647M

Total Liabilities

$36M

Stockholders' Equity

$611M

Cash & Equivalents

$325M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$194,000	$0	—
Operating Income	-$92M	-$67M	-36.2%
Net Income	-$90M	-$63M	-41.9%